Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to 49.01%.

  • MediWound's EBITDA Margin rose 1872400.0% to 49.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.85%, marking a year-over-year increase of 1072500.0%. This contributed to the annual value of 149.43% for FY2024, which is 1134200.0% down from last year.
  • MediWound's EBITDA Margin amounted to 49.01% in Q3 2025, which was up 1872400.0% from 233.51% recorded in Q2 2025.
  • MediWound's EBITDA Margin's 5-year high stood at 233.51% during Q2 2025, with a 5-year trough of 236.26% in Q3 2024.
  • For the 5-year period, MediWound's EBITDA Margin averaged around 37.87%, with its median value being 52.39% (2021).
  • In the last 5 years, MediWound's EBITDA Margin tumbled by -1904200bps in 2024 and then soared by 1872400bps in 2025.
  • MediWound's EBITDA Margin (Quarter) stood at 75.71% in 2021, then rose by 15bps to 64.36% in 2022, then soared by 49bps to 32.86% in 2023, then tumbled by -103bps to 66.85% in 2024, then rose by 27bps to 49.01% in 2025.
  • Its last three reported values are 49.01% in Q3 2025, 233.51% for Q2 2025, and 18.33% during Q1 2025.